Trial NCT04465734

View at ClinicalTrials.gov 
Org. Study IDs: HLX10-009-HCC301

Last trial update was posted on 2022-05-05

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma (HCC)

Stopping Reasons

The trial used sorafenib as a control drug. It's not suitable now(after the A+T has been approved).The sponsor terminated the trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID